Home › NDC Lookup › J-codes › J9198
J9198

J9198 – Injection, gemcitabine hydrochloride, (infugem), 100 mg · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 10 NDCs crosswalked

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

📋 J9198 summary

J9198 is a HCPCS Level II J-code used to bill gemcitabine hydrochloride, (infugem), 100 mg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Code J9198 NDC-Crosswalk 10 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ9198
DescriptorInjection, gemcitabine hydrochloride, (infugem), 100 mg
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs10
Data periodNot available in current dataset
Last updatedSource date not available

🧾 Billing & reimbursement HCPCS · CMS

Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionInjection, gemcitabine hydrochloride, (infugem), 100 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2021-01-01
Date added2020-07-01
Source: CMS HCPCS Level II code file (imported via admin).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J9198 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J9198 CROSSWALKED NDCs

10 NDCs map to J9198. Bill units = how many HCPCS units one package represents.
NDC (11-digit)DrugLabelerPackageStrength Bill units NADAC / unit StatusSource
62756-0008-60 INFUGEM (LATEX-FREE) 1300 MG/130 ML Unknown — — 0.1 — — PDAC
62756-0073-60 INFUGEM (LATEX-FREE) 1200 MG/120 ML Unknown — — 0.1 — — PDAC
62756-0102-60 INFUGEM (LATEX-FREE) 1400 MG/140 ML Unknown — — 0.1 — — PDAC
62756-0219-60 INFUGEM (LATEX-FREE) 1500 MG/150 ML Unknown — — 0.1 — — PDAC
62756-0321-60 INFUGEM (LATEX-FREE) 1600 MG/160 ML Unknown — — 0.1 — — PDAC
62756-0438-60 INFUGEM (LATEX-FREE) 1700 MG/170 ML Unknown — — 0.1 — — PDAC
62756-0533-60 INFUGEM (LATEX-FREE) 1800 MG/180 ML-0.9% Unknown — — 0.1 — — PDAC
62756-0614-60 INFUGEM (LATEX-FREE) 1900 MG/190 ML Unknown — — 0.1 — — PDAC
62756-0746-60 INFUGEM (LATEX-FREE) 2000 MG/200 ML Unknown — — 0.1 — — PDAC
62756-0974-60 INFUGEM (LATEX-FREE) 2200 MG/220 ML Unknown — — 0.1 — — PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$7.9K
Medicare paid
$6.2K
Submitted services
1,150
Denial rate
75.7%
Allowed / service
$28.10
Submitted charges
$46.2K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J9198 is utilized CMS · BY PROVIDER · 2024

Medicare Part B services for this code by the rendering provider's state — 260 services across 1 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
10 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J9198 billing FAQ

What is HCPCS code J9198?
J9198 is a HCPCS Level II J-code used to bill Injection, gemcitabine hydrochloride, (infugem), 100 mg under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J9198?
10 NDCs currently map to J9198 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9198 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.